GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (OTCPK:SHPHF) » Definitions » Pretax Margin %

Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) Pretax Margin % : -15.93% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Sihuan Pharmaceutical Holdings Group Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sihuan Pharmaceutical Holdings Group's Pre-Tax Income for the six months ended in Dec. 2023 was $-18.0 Mil. Sihuan Pharmaceutical Holdings Group's Revenue for the six months ended in Dec. 2023 was $112.7 Mil. Therefore, Sihuan Pharmaceutical Holdings Group's pretax margin for the quarter that ended in Dec. 2023 was -15.93%.

The historical rank and industry rank for Sihuan Pharmaceutical Holdings Group's Pretax Margin % or its related term are showing as below:

SHPHF' s Pretax Margin % Range Over the Past 10 Years
Min: -97.32   Med: 47.03   Max: 89.72
Current: -8.67


SHPHF's Pretax Margin % is ranked worse than
68.04% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 4.245 vs SHPHF: -8.67

Sihuan Pharmaceutical Holdings Group Pretax Margin % Historical Data

The historical data trend for Sihuan Pharmaceutical Holdings Group's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sihuan Pharmaceutical Holdings Group Pretax Margin % Chart

Sihuan Pharmaceutical Holdings Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -84.18 31.08 16.32 -97.32 -8.67

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.60 3.83 -303.88 -3.13 -15.93

Competitive Comparison of Sihuan Pharmaceutical Holdings Group's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sihuan Pharmaceutical Holdings Group's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's Pretax Margin % falls into.



Sihuan Pharmaceutical Holdings Group Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Sihuan Pharmaceutical Holdings Group's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-22.585/260.572
=-8.67 %

Sihuan Pharmaceutical Holdings Group's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-17.956/112.719
=-15.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sihuan Pharmaceutical Holdings Group  (OTCPK:SHPHF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Sihuan Pharmaceutical Holdings Group Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Sihuan Pharmaceutical Holdings Group's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) Business Description

Traded in Other Exchanges
Address
Zhubang 2000 Business Centre, 22nd Floor, Building 4, West Balizhuang, Chaoyang District, Beijing, CHN, 100025
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.